Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. diamantweg 4 1812 rc alkmaar - pancreatine 300 mg/stuk ; samenstelling overeenkomend met amylase 18000 ph. eur. e/st ; lipase 25000 ph. eur. e/st ; protease 1000 ph. eur. e/st - maagsapresistente capsule, hard - cetylalcohol ; dimeticon (e 900) ; gelatine (e 441) ; hypromelloseftalaat ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; macrogol 4000 ; natriumlaurilsulfaat ; titaandioxide (e 171) ; triethylcitraat (e 1505), cetylalcohol ; dimeticon (e 900) ; gelatine (e 441) ; hypromelloseftalaat ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; macrogol 4000 ; natriumlaurilsulfaat (e 487) ; titaandioxide (e 171) ; triethylcitraat (e 1505)

Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. diamantweg 4 1812 rc alkmaar - mesalazine 1200 mg/stuk - maagsapresistente tablet - carmellose natrium (e 466) ; carnaubawas (e 903) ; copolymeer van methacrylzuur-methylmethacrylaat (1:1) ; copolymeer van methacrylzuur-methylmethacrylaat (1:2)(e 1207) ; ijzeroxide rood (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide, gehydrateerd (e 551) ; stearinezuur (e 570) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505), carmellose natrium (e 466) ; carnaubawas (e 903) ; copolymeer van methacrylzuur-methylmethacrylaat (1:2) ; copolymeer van methacrylzuur-methylmethacrylaat (1:1) ; ijzeroxide rood (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide, gehydrateerd (e 551) ; stearinezuur (e 570) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505)

Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. diamantweg 4 1812 rc alkmaar - ondansetron 4 mg/stuk - orodispergeerbare tablet - aardbeiensmaakstof ; aspartaam (e 951) ; ethanol ; gelatine (e 441) ; mannitol (d-) (e 421) ; methylparahydroxybenzoaat (e 218) ; propylparahydroxybenzoaat (e 216)

Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. diamantweg 4 1812 rc alkmaar - ondansetron 8 mg/stuk - orodispergeerbare tablet - aardbeiensmaakstof ; aspartaam (e 951) ; ethanol ; gelatine (e 441) ; mannitol (d-) (e 421) ; methylparahydroxybenzoaat (e 218) ; propylparahydroxybenzoaat (e 216)

Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. diamantweg 4 1812 rc alkmaar - misoprostol 200 µg/stuk - tablet - castorolie, gehydreerd ; cellulose, microkristallijn (e 460(i)) ; hypromellose (e 464) ; natriumzetmeelglycolaat, castorolie, gehydreerd ; cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; natriumzetmeelglycolaat

Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. diamantweg 4 1812 rc alkmaar - cabergoline 0,5 mg/stuk - tablet - lactose 0-water ; leucine, (l-)

Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. joop geesinkweg 901 1114 ab amsterdam - timotheegraspollenextract "alk" 75000 e/stuk - lyofilisaat voor oraal gebruik - gelatine, afkomstig van vis ; mannitol (d-) (e 421) ; natriumhydroxide (e 524)

Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. diamantweg 4 1812 rc alkmaar - barnidipinehydrochloride 20 mg/stuk samenstelling overeenkomend met ; barnidipine 18,6 mg/stuk - capsule met gereguleerde afgifte, hard - carmellose (e 466) ; ethylcellulose (e 462) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; polysorbaat 80 (e 433) ; propyleenglycol (e 1520) ; saccharose ; schellak (e 904) ; talk (e 553 b) ; titaandioxide (e 171) ; zwarte inkt

Европейский союз - голландский - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccins - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.

Нидерланды - голландский - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

originalis b.v. diamantweg 4 1812 rc alkmaar - lanreotideacetaat samenstelling overeenkomend met ; ; lanreotide 246 mg/g - oplossing voor injectie - azijnzuur (e 260), geconcentreerd ; water voor injectie, - lanreotide